595 Madison Avenue
New York, NY 10017
917 289 2776
Sector(s): Financial Services
Industry: Shell Companies
|Mr. Humphrey P. Polanen||CEO & Chairman||N/A||N/A||1950|
|Ms. Weixuan Luo CPA, MS||Chief Financial Officer||N/A||N/A||1973|
Deep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.
Deep Medicine Acquisition Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.